197 related articles for article (PubMed ID: 24283115)
1. Fondaparinux in heparin-induced thrombocytopenia.
Gevaert A; Smets H; Vercauteren R
Acta Cardiol; 2013 Oct; 68(5):517-20. PubMed ID: 24283115
[TBL] [Abstract][Full Text] [Related]
2. [Fondaparinux treatment in heparin induced thrombocytopenia:a case report].
Ozsu S; Korkmaz A; Bülbül Y; Oztuna F; Ozlü T
Tuberk Toraks; 2011; 59(2):178-83. PubMed ID: 21740395
[TBL] [Abstract][Full Text] [Related]
3. Chronic fondaparinux use in a hemodialysis patient with heparin-induced thrombocytopenia type II and extracorporeal circuit thrombosis-a case report and review of the literature.
Brown P; Jay R; Fox A; Oliver M
Hemodial Int; 2013 Jul; 17(3):444-9. PubMed ID: 23216938
[TBL] [Abstract][Full Text] [Related]
4. Fondaparinux for the treatment of acute heparin-induced thrombocytopenia: a single-center experience.
Grouzi E; Kyriakou E; Panagou I; Spiliotopoulou I
Clin Appl Thromb Hemost; 2010 Dec; 16(6):663-7. PubMed ID: 19825921
[TBL] [Abstract][Full Text] [Related]
5. Treatment of heparin-induced thrombocytopenia with fondaparinux.
Harenberg J; Jörg I; Fenyvesi T
Haematologica; 2004 Aug; 89(8):1017-8. PubMed ID: 15339691
[TBL] [Abstract][Full Text] [Related]
6. The treatment of deep venous thrombosis, including the newer agents.
Rectenwald JE; Wakefield TW
Dis Mon; 2005; 51(2-3):104-11. PubMed ID: 15900261
[No Abstract] [Full Text] [Related]
7. Use of fondaparinux in a pregnant woman with pulmonary embolism and heparin-induced thrombocytopenia.
Ciurzyński M; Jankowski K; Pietrzak B; Mazanowska N; Rzewuska E; Kowalik R; Pruszczyk P
Med Sci Monit; 2011 May; 17(5):CS56-9. PubMed ID: 21525816
[TBL] [Abstract][Full Text] [Related]
8. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
9. Fondaparinux as a safe alternative for managing heparin-induced thrombocytopenia in postoperative cardiac surgery patients.
Cegarra-Sanmartín V; González-Rodríguez R; Paniagua-Iglesias P; Santamaría-Ortiz A; Cueva LF; Galán-Serrano J; Moral-García MV
J Cardiothorac Vasc Anesth; 2014 Aug; 28(4):1008-12. PubMed ID: 24439171
[TBL] [Abstract][Full Text] [Related]
10. [Successful treatment with fondaparinux in heparin-induced thrombocytopenia and thrombosis].
Seculini Patiño CE; Pascualini MF; Tabares AH
Medicina (B Aires); 2015; 75(5):307-10. PubMed ID: 26502466
[TBL] [Abstract][Full Text] [Related]
11. [Recurrent pulmonary embolism in a patient with heparin-induced thrombocytopenia].
Jankowski K; Ozdzeńska-Milke E; Lichodziejewska B; Huba M; Ciurzyński M; Pruszczyk P
Pol Arch Med Wewn; 2007; 117(11-12):524-6. PubMed ID: 18363253
[TBL] [Abstract][Full Text] [Related]
12. Fondaparinux in a critically Ill patient with heparin-induced thrombocytopenia: A case report.
He Y; He H; Liu D; Long Y; Su L; Cheng W
Medicine (Baltimore); 2018 Sep; 97(37):e12236. PubMed ID: 30212955
[TBL] [Abstract][Full Text] [Related]
13. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
[TBL] [Abstract][Full Text] [Related]
14. [Heparin-induced thrombocythopenia in a patient with massive pulmonary embolism and dilated cardiomyopathy, successfuly treated with fondaparinux - a case report].
Nowicka A; Kandziora M; Szymanowska K; Michalski M; Piatkowska A; Biegalski W; Dankowski R; Poprawski K; Wierzchowiecki M
Kardiol Pol; 2008 Dec; 66(12):1306-8. PubMed ID: 19169978
[TBL] [Abstract][Full Text] [Related]
15. Heparin-induced thrombocytopenia successfully treated with fondaparinux.
Seldrum S; Lambert M; Hainaut P
Acta Clin Belg; 2009; 64(2):144-6. PubMed ID: 19432027
[TBL] [Abstract][Full Text] [Related]
16. Deep venous thrombosis and pulmonary embolism. Part 1. Initial treatment: usually a low-molecular-weight heparin.
Prescrire Int; 2013 Apr; 22(137):99-101, 103-4. PubMed ID: 23662321
[TBL] [Abstract][Full Text] [Related]
17. Heparins, low-molecular-weight heparins, and pentasaccharides.
Dinwoodey DL; Ansell JE
Clin Geriatr Med; 2006 Feb; 22(1):1-15, vii. PubMed ID: 16377464
[TBL] [Abstract][Full Text] [Related]
18. Heparin-induced thrombocytopenia treated with fondaparinux: single center experience.
Dulicek P; Ivanova E; Kostal M; Fiedlerova Z; Sadilek P; Hirmerova J
Int Angiol; 2020 Feb; 39(1):76-81. PubMed ID: 31782283
[TBL] [Abstract][Full Text] [Related]
19. Successful use of fondaparinux in a patient with a mechanical heart valve replacement and a history of heparin-induced thrombocytopenia.
Corbett TL; Elher KS; Garwood CL
J Thromb Thrombolysis; 2010 Oct; 30(3):375-7. PubMed ID: 20571919
[TBL] [Abstract][Full Text] [Related]
20. Novel anticoagulants for the prevention and treatment of venous thromboembolism.
Weltermann A; Kyrle PA; Eichinger S
Wien Med Wochenschr; 2003; 153(19-20):426-33. PubMed ID: 14648923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
